EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS Inability of Human Induced Pluripotent Stem Cell-Hematopoietic Derivatives to Downregulate MicroRNAs In Vivo Reveals a Block in Xenograft Hematopoietic Regeneration

Hematopoietic stem cells (HSCs) can regenerate the entire hematopoietic system in vivo, providing the most relevant criteria to measure candidate HSCs derived from human embryonic stem cell (hESC) or induced pluripotent stem cell (hiPSC) sources. Here we show that, unlike primitive hematopoietic cells derived from hESCs, phenotypically identical cells derived from hiPSC are more permissive to graft the bone marrow of xenotransplantation recipients. Despite establishment of bone marrow graft, hiPSC‐derived cells fail to demonstrate hematopoietic differentiation in vivo. However, once removed from recipient bone marrow, hiPSC‐derived grafts were capable of in vitro multilineage hematopoietic differentiation, indicating that xenograft imparts a restriction to in vivo hematopoietic progression. This failure to regenerate multilineage hematopoiesis in vivo was attributed to the inability to downregulate key microRNAs involved in hematopoiesis. Based on these analyses, our study indicates that hiPSCs provide a beneficial source of pluripotent stem cell‐derived hematopoietic cells for transplantation compared with hESCs. Since use of the human–mouse xenograft models prevents detection of putative hiPSC‐derived HSCs, we suggest that new preclinical models should be explored to fully evaluate cells generated from hiPSC sources. STEM CELLS 2012; 30:131–139.

[1]  S. Morrison,et al.  Human and rhesus macaque hematopoietic stem cells cannot be purified based only on SLAM family markers. , 2011, Blood.

[2]  C. Hansen,et al.  MicroRNA-146a disrupts hematopoietic differentiation and survival. , 2011, Experimental hematology.

[3]  Alessandra Biffi,et al.  Identification of Hematopoietic Stem Cell–Specific miRNAs Enables Gene Therapy of Globoid Cell Leukodystrophy , 2010, Science Translational Medicine.

[4]  J. Dick,et al.  Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgc-null recipients. , 2010, Blood.

[5]  Hannele Ruohola-Baker,et al.  Characterization of microRNAs involved in embryonic stem cell states. , 2010, Stem cells and development.

[6]  Russell J. Taylor,et al.  Bioluminescent Imaging Demonstrates That Transplanted Human Embryonic Stem Cell‐Derived CD34+ Cells Preferentially Develop into Endothelial Cells , 2009, Stem cells.

[7]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[8]  P. Quesenberry,et al.  Problems in the promised land: status of adult marrow stem cell biology. , 2009, Experimental hematology.

[9]  N. Naumann,et al.  In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene. , 2009, The Journal of clinical investigation.

[10]  R. Moon,et al.  Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. , 2009, Cell stem cell.

[11]  Atul J Butte,et al.  MicroRNA profiling of human-induced pluripotent stem cells. , 2009, Stem cells and development.

[12]  Megan F. Cole,et al.  Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells , 2008, Cell.

[13]  M. Stojkovic,et al.  Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. , 2008, Cell stem cell.

[14]  G. Daley,et al.  Selective Blockade of MicroRNA Processing by Lin28 , 2008, Science.

[15]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[16]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[17]  M. Bhatia.  Hematopoiesis from Human Embryonic Stem Cells , 2007, Annals of the New York Academy of Sciences.

[18]  R. Shivdasani.  MicroRNAs: regulators of gene expression and cell differentiation. , 2006, Blood.

[19]  G. Daley,et al.  Embryonic stem cell-derived hematopoietic stem cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Ruohola-Baker,et al.  Stem cell division is regulated by the microRNA pathway , 2005, Nature.

[21]  J. Dick,et al.  Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression , 2005, The Journal of experimental medicine.

[22]  M. Bhatia,et al.  Hierarchical and ontogenic positions serve to define the molecular basis of human hematopoietic stem cell behavior. , 2005, Developmental cell.

[23]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[24]  Christof von Kalle,et al.  Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells , 2004, PLoS biology.

[25]  L. Coulombel.  Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays , 2004, Oncogene.

[26]  Lisheng Wang,et al.  Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. , 2004, Immunity.

[27]  S. Moon,et al.  Human embryonic stem cells express a unique set of microRNAs. , 2004, Developmental biology.

[28]  Lisheng Wang,et al.  Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. , 2003, Blood.

[29]  J. Dick,et al.  Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells , 2003, Nature Medicine.

[30]  M. Yamaguchi,et al.  Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. , 2003, Blood.

[31]  I. Fichtner,et al.  Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems , 2002, British Journal of Cancer.

[32]  Mamoru Ito,et al.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. , 2002, Blood.

[33]  G. Daley,et al.  HoxB4 Confers Definitive Lymphoid-Myeloid Engraftment Potential on Embryonic Stem Cell and Yolk Sac Hematopoietic Progenitors , 2002, Cell.

[34]  F. Wolber,et al.  Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. , 2002, Blood.

[35]  R Storb,et al.  Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. , 2001, The New England journal of medicine.

[36]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Heim,et al.  Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency , 2000, Immunological reviews.

[38]  J. Tisdale,et al.  Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors , 1997 .

[40]  J. Dick,et al.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[41]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[42]  J. Rossi,et al.  A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma , 1996 .

[43]  A. Bradley,et al.  Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines , 1984, Nature.

[44]  G. Daley,et al.  Autologous blood cell therapies from pluripotent stem cells. , 2010, Blood reviews.

[45]  M. Bhatia.  Hematopoietic development from human embryonic stem cells. , 2007, Hematology. American Society of Hematology. Education Program.

[46]  R. Burt,et al.  Embryonic Stem Cells As an Alternate Marrow Donor Source: Engraftment without Graft-Versus-Host Disease , 2004 .

[47]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. , 1997, The New England journal of medicine.

[48]  J. Rossi,et al.  A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. , 1996, The New England journal of medicine.